You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dry eye, refractive surgery, 0.05% cyclosporine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dry Eye Trial in Beijing (artificial tear eyedrops, 0.05% cyclosporine eyedrops)

Recruiting
  • Dry Eye
  • artificial tear eyedrops
  • 0.05% cyclosporine eyedrops
  • Beijing, Beijing, China
    Hong Qi
Sep 12, 2023

Dry Eye Syndromes Trial in Korea, Republic of (SCAI-001 0.01% eyedrop, SCAI-001 0.02% eyedrop, Restasis 0.05% eyedrop)

Recruiting
  • Dry Eye Syndromes
  • SCAI-001 0.01% eyedrop
  • +2 more
  • Bucheon, Korea, Republic of
  • +10 more
Feb 21, 2023

Dry Eye, Dry Eye After LASIK-Laser in Situ Keratomileusis Trial (IPL+LLLT)

Not yet recruiting
  • Dry Eye
  • Dry Eye After LASIK-Laser in Situ Keratomileusis
  • IPL+LLLT
  • (no location specified)
Apr 5, 2023

AST Combined With 0.05% Cyclosporin Eye Drop Improve Corneal

Completed
  • Sjogren's Syndrome
  • +2 more
  • Autologous serum tears combined with 0.05% cyclosporin eye drop
  • Chengdu, Sichuan, China
    Hospital of Chengdu University of Traditional Chinese Medicine
Aug 25, 2023

Dry Eye Disease Trial in United States (CequaTM (Cyclosporine 0.09%) ophthalmic solution)

Completed
  • Dry Eye Disease
  • CequaTM (Cyclosporine 0.09%) ophthalmic solution
  • Fort Myers, Florida
  • +4 more
Sep 8, 2022

Dry Eye Disease Trial in Waterloo (0.09% cyclosporine A ophthalmic solution)

Recruiting
  • Dry Eye Disease
  • 0.09% cyclosporine A ophthalmic solution
  • Waterloo, Ontario, Canada
    University of Waterloo
Jul 13, 2023

Dry Eye Trial in Guangzhou (Cyclosporine, oculus keratograph, in vivo laser confocal microscopy, Functional slit lamp

Recruiting
  • Dry Eye
  • Cyclosporine
  • oculus keratograph, in vivo laser confocal microscopy, Functional slit lamp biomicroscopy
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
Feb 9, 2022

Clinical Outcomes of Cyclosporine Eye Drops in Herpetic Keratitis Trial in Al Farwaniyah (cyclosporine A 0.05% eye drops)

Recruiting
  • Clinical Outcomes of Cyclosporine Eye Drops in Herpetic Keratitis
  • cyclosporine A 0.05% eye drops
  • Al Farwānīyah, Farwanyia, Kuwait
    Farwanyia Hospital
Jan 31, 2023

Patients Developing Chronic Dry Eye After Refractive Surgery

Not yet recruiting
  • Dry Eye
  • FS-LASIK
  • Beijing, Beijing, China
    Peking University Third Hospital
Oct 29, 2022

Dry Eye Trial in Hemet, Laguna Hills, Brecksville (Klarity CL, Cylcosporine 0.1%/Loteprednol Etabonate 0.2% Preservative Free)

Completed
  • Dry Eye
  • Klarity CL, Cylcosporine 0.1%/Loteprednol Etabonate 0.2% Preservative Free
  • Hemet, California
  • +2 more
Dec 30, 2022

Dry Eye Disease Trial in Hanzhou (Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops)

Not yet recruiting
  • Dry Eye Disease
  • Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops
  • Hanzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 21, 2023

Vernal Keratoconjunctivitis, Cyclosporine 0.05% Eye Drops Trial in Nanchang (Cyclosporine 0.05% eye drops, Loteprednol Etabonate

Completed
  • Vernal Keratoconjunctivitis
  • Cyclosporine 0.05% Eye Drops
  • Cyclosporine 0.05% eye drops
  • Loteprednol Etabonate 0.5% and Tobramycin Eye Drops 0.3%
  • Nanchang, Jiangxi, China
    the Second Affiliated Hospital of Nanchang University
Apr 28, 2022

Dry Eye Disease Trial in Jakarta Pusat (Diquafosol sodium 3%, Sodium hyaluronate 0.1%)

Recruiting
  • Dry Eye Disease
  • Diquafosol sodium 3%
  • Sodium hyaluronate 0.1%
  • Jakarta Pusat, Jakarta, Indonesia
    RSUPN Dr. Cipto Mangunkusumo
Nov 24, 2023

GVHD in Eye Trial in Beijing (Cyclosporine, tacrolimus)

Completed
  • Graft Versus Host Disease in Eye
  • Beijing, Beijing, China
    Peking University Third Hospital
Mar 14, 2022

Dry Eye Trial in Brecksville (Cyclosporin, Loteprednol Etabonate, Dexamethasone Ophthalmic 0.4 Mg Ophthalmic Insert)

Completed
  • Dry Eye
  • Brecksville, Ohio
    Cleveland Eye Clinic
May 9, 2022

Dry Eye Syndrome Trial in Seoul (TJO-087, Cyclosporine ophthalmic solution 0.05%)

Recruiting
  • Dry Eye Syndrome
  • TJO-087
  • Cyclosporine ophthalmic solution 0.05%
  • Seoul, Korea, Republic of
    Hyo Myung, Kim
Feb 8, 2022

Dry Eye Syndromes Trial (Oph1, Restasis)

Not yet recruiting
  • Dry Eye Syndromes
  • (no location specified)
Jan 7, 2022

Dry Eye in Patients Operated on for Ametropia by LASIK Surgery

Completed
  • Ametropia
  • Describe the evolution of dry eye between 1 month and 3 months post-LASIK
  • Lyon, Rhone, France
    Hôpital Edouard Herriot
Dec 8, 2021

Keratoconjunctivitis Sicca, Dry Eye Disease Trial in Cleveland (OTX-101 0.05%, OTX-101 0.09%, Vehicle)

Completed
Has Results
  • Keratoconjunctivitis Sicca
  • Dry Eye Disease
  • OTX-101 0.05%
  • +2 more
  • Cleveland, Ohio
    (unnamed)
Aug 26, 2022

Ocular Surface Disease, Ocular Inflammation Trial in Rome (CycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsion, cationorm eye

Active, not recruiting
  • Ocular Surface Disease
  • Ocular Inflammation
  • CycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsion
  • cationorm eye drops
  • Rome, Italy
    University Campus Bio Medico
Jan 5, 2022

Cataract Trial in United States (Clobetasol Propionate, Vehicle)

Completed
Has Results
  • Cataract
  • Sun City, Arizona
  • +17 more
Nov 30, 2022

MCS vs ReLACS, Pain Perception Postoperative, Early Anesthesia vs Standard Anesthesia Trial in Brampton (M-IBCS, ReLA-IBCS

Recruiting
  • MCS vs ReLACS
  • +3 more
  • M-IBCS
  • +2 more
  • Brampton, Ontario, Canada
    Uptown Eye Specialist
Jul 27, 2022

Cataract Trial in United States (Clobetasol propionate, Vehicle)

Completed
Has Results
  • Cataract
  • Chandler, Arizona
  • +21 more
Nov 30, 2022

Dry Eye Trial in Nashville (nanomicellular cyclosporine 0.09%, Lifitegrast)

Recruiting
  • Dry Eye
  • Nashville, Tennessee
    Toyos Clinic
Oct 4, 2021

Moderate to Severe Dry Eye Trial in Seoul (Cyclosporine 0.1% (Ikervis®) eye drop)

Recruiting
  • Moderate to Severe Dry Eye
  • Cyclosporine 0.1% (Ikervis®) eye drop
  • Seoul, Korea, Republic of
    Severance Hospital
Feb 25, 2021